Scale Up Program client Cold Plasma Group awarded US patent

Initially targeting the cannabis industry, Cold Plasma Group (CPG) has developed a patented platform technology which uses cold plasma treatments for the sterilization of plant material.

“CPG’s cold plasma technology destroys bacterial and fungal species without altering the quality of cannabis flower nor the concentrations of cannabinoids and terpenes,” says Dr. Florina Truica, Chief Technology Officer for CPG, who was introduced for the first time to the problem of microbial contamination for cannabis medical products in 2017, following a discussion with Dr. Luc C. Deschenes, a cannabis industry executive and industry scientist. Dr. Truica developed the concept of cold plasma treatments specifically tailored for the microbial remediation of plant material, combining strong germicidal efficacy with a gentle, non-destructive approach. Importantly, the technology was developed to be eco-friendly and fully compatible with organic practices by avoiding the use of chemicals altogether. After successful initial trials and validation, Dr. Truica and Mr. David Johnson co-founded Cold Plasma Group in early 2019 to bring this innovation to market.

Read more at: Queen's University Partnerships and Innovation